The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts

被引:190
作者
Georgiadou, Sarah P. [2 ,3 ]
Sipsas, Nikolaos V. [2 ,3 ]
Marom, Edith M. [4 ]
Kontoyiannis, Dimitrios P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA
[2] Laikon Gen Hosp, Dept Pathophysiol, Infect Dis Unit, Athens, Greece
[3] Univ Athens, Sch Med, Athens 11528, Greece
[4] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
HIGH-RESOLUTION CT; BONE-MARROW-TRANSPLANTATION; CHEST COMPUTED-TOMOGRAPHY; HIV IMMUNOCOMPROMISED PATIENTS; POSITRON-EMISSION-TOMOGRAPHY; PULMONARY FUNGAL-INFECTIONS; STEM-CELL TRANSPLANTATION; CARE CANCER CENTER; AIR CRESCENT SIGN; THIN-SECTION CT;
D O I
10.1093/cid/cir122
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The halo sign is a CT finding of ground-glass opacity surrounding a pulmonary nodule or mass. The reversed halo sign is a focal rounded area of ground-glass opacity surrounded by a crescent or complete ring of consolidation. In severely immunocompromised patients, these signs are highly suggestive of early infection by an angioinvasive fungus. The halo sign and reversed halo sign are most commonly associated with invasive pulmonary aspergillosis and pulmonary mucormycosis, respectively. Many other infections and noninfectious conditions, such as neoplastic and inflammatory processes, may also manifest with pulmonary nodules associated with either sign. Although nonspecific, both signs can be useful for preemptive initiation of antifungal therapy in the appropriate clinical setting. This review aims to evaluate the diagnostic value of the halo sign and reversed halo sign in immunocompromised hosts and describes the wide spectrum of diseases associated with them.
引用
收藏
页码:1144 / 1155
页数:12
相关论文
共 115 条
[1]   Another cause of reverse halo sign: Wegener's granulomatosis [J].
Agarwal, R. ;
Aggarwal, A. N. ;
Gupta, D. .
BRITISH JOURNAL OF RADIOLOGY, 2007, 80 (958) :849-850
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Glossary of terms for CT of the lungs: Recommendations of the Nomenclature Committee of the Fleischner Society [J].
Austin, JHM ;
Muller, NL ;
Friedman, PJ ;
Hansell, DM ;
Naidich, DP ;
RemyJardin, M ;
Webb, WR ;
Zerhouni, EA .
RADIOLOGY, 1996, 200 (02) :327-331
[4]   Phaeohyphomycosis in a Tertiary Care Cancer Center [J].
Ben-Ami, Ronen ;
Lewis, Russell E. ;
Raad, Issam I. ;
Kontoyiannis, Dimitrios P. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (08) :1033-1041
[5]  
BENAMORE RE, 2007, BRIT J RADIOL, V80, P162
[6]  
BERNARD A, 1995, ANN CHIR, V49, P849
[7]   INVASIVE PULMONARY ASPERGILLOSIS - MRI, CT, AND PLAIN RADIOGRAPHIC FINDINGS AND THEIR CONTRIBUTION FOR EARLY DIAGNOSIS [J].
BLUM, U ;
WINDFUHR, M ;
BUITRAGOTELLEZ, C ;
SIGMUND, G ;
HERBST, EW ;
LANGER, M .
CHEST, 1994, 106 (04) :1156-1161
[8]   NODULAR PULMONARY-LESIONS IN IMMUNOCOMPROMISED PATIENTS [J].
BLUM, U ;
WINDFUHR, M ;
BUITRAGOTELLEZ, C ;
STOVER, B ;
KREISEL, B ;
LINDEMANN, A ;
HERBST, EW ;
LANGER, M .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1994, 161 (04) :292-299
[9]   Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: Kinetics of CT morphology and correlation with clinical findings and outcome [J].
Brodoefel, Harald ;
Vogel, Monika ;
Hebart, Holger ;
Einsele, Hermann ;
Vonthein, Reinhard ;
Claussen, Claus ;
Horger, Marius .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 187 (02) :404-413
[10]   Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients [J].
Brook, O. R. ;
Guralnik, L. ;
Hardak, E. ;
Oren, I. ;
Sprecher, H. ;
Zuckerman, T. ;
Engel, A. ;
Yigla, M. .
HEMATOLOGICAL ONCOLOGY, 2009, 27 (02) :102-106